Visible light-induced singlet oxygen-mediated intracellular disassembly of polymeric micelles co-loaded with a photosensitizer and an anticancer drug for enhanced photodynamic therapy † Gurusamy Saravanakumar, Junseok Lee, Jihoon Kim and Won Jong Kim* Herein, we report a biocompatible amphiphilic block copolymer micelle bearing a singlet oxygen-sensitive vinyldithioether cleavable linker at the core-shell junction, which undergoes singlet oxygenmediated photocleavage in the presence of visible light. The micelle facilitates the light-responsive release of singlet oxygen and an anticancer drug for enhanced photodynamic therapy.
Photodynamic therapy (PDT) is emerging as a promising treatment modality for several cancers and other non-malignant diseases owing to its unique advantages such as non-invasiveness and less systemic toxicity. 1 This modality works by administering a photosensitizer (PS) and then activating it with a light of specific wavelength to generate reactive oxygen species, primarily singlet oxygen ( 1 O 2 ), which induce apoptosis or necrosis of the tumor cells. Despite its significant advantages, however, the clinical potential of PDT is limited by factors such as poor aqueous solubility of PSs and nonspecific accumulation of PSs at the normal tissues. To surmount these issues, several nanocarrier platforms such as liposomes, 2 polymeric micelles, 3 dendrimers, 4 and self-assembled polymeric nanoparticles 5 have been investigated. Another important concern of PDT is the depletion of ambient tumor oxygen through rapid and continuous photochemical conversion of 3 O 2 to 1 O 2 at high fluence rates, which can cause acute local hypoxic conditions and disrupt the photodynamic process, thereby reducing the treatment effectiveness. 6 Integration of PDT with other treatment modalities such as photothermal therapy 7 or chemotherapy 8 holds great promise to circumvent the above critical limitation, because such a combination therapy produces additive or synergistic therapeutic efficacy by targeting different cellular or molecular pathways. It is particularly gratifying to note that the results from recent preclinical studies have also indicated that combining PDT with chemotherapy can improve anticancer activity by overcoming anticancer drug resistance 9 which is a major impediment to the success of chemotherapy. Considering highly liphophilic and molecularly diverse characteristics of both PSs and anticancer drugs, however, the development of smart and efficient carriers for the co-delivery of PSs and anticancer drugs is crucial to realize the full potential of the combination therapy. For such co-delivery, we envisioned that polymeric micelles integrated with photo-responsive moieties could be a potential carrier. Firstly, its core-shell structures could readily encapsulate multiple poorly water-soluble active agents into the hydrophobic core with high loading capacity. Secondly, without any additional trigger mechanism, the co-loaded anticancer drugs can be effectively released in the tumor cell to exert their therapeutic effects because light is an integral part of the PDT process. Although light-responsive micellar systems have been developed by incorporating photochromic moieties such as azobenzene, 10 2-diazo-1,2-napthoquinone, 11 O-nitrobenzyl 12 or coumarin 13 into their structure, unfortunately, most of them respond only to the harmful UV light or multi-photon excitation that requires enormously high laser power. Moreover, these systems are mostly based on non-degradable polymeric compositions with limited biocompatibility. Thus, there is an increasing need to develop safe, low toxic and more efficient carrier systems that could respond to the biomedically benign visible or near-infra-red light. It should also be emphasized that, to date, no significant effort has been made to the development of rationally designed light-responsive carriers for dual-drug delivery.
In this study, we have designed and explored a novel biocompatible visible-light responsive amphiphilic poly(ethylene glycol)-block-poly(caprolactone) copolymer ( S3b , ESI †), in which all the resonance peaks corresponding to the PEG and PCL segments were observed. Further, the composition of the copolymer was estimated by comparing the integration ratios of the peaks at 3.35 ppm from the methyl protons (CH 3 -) of PEG and the peak at 4.03 ppm from the methylene protons (-CH 2 -O-) of PCL segments. GPC analysis of the block copolymer showed a unimodal molecular weight distribution (Fig. S4, ESI †) . For comparison, a control C-PEG-b-PCL copolymer of similar composition without the linker was also synthesized. The compositions of these block copolymers are summarized in Table S1 (ESI †).
Owing to its amphiphilicity, the 1 O 2 -PEG-b-PCL copolymer can form a self-assembled micellar structure ( 1 O 2 -PM) under aqueous conditions. The dynamic light scattering measurements of micelles showed unimodal size distribution with an average particle size of 40 AE 3.1 nm and the TEM image indicated that they have a spherical morphology (Fig. S5, ESI † As shown in Fig. S6a (ESI †), the characteristic cis-alkene peak at d 6.1 ppm of the linker completely disappeared, whereas all the characteristic peaks of the polymers were observed without laser irradiation. This result was further supported by the GPC analysis ( , 3 h). As expected, compared to the spherical micelles before irradiation, highly degraded irregular aggregated micelles were observed after laser irradiation (Fig. 1c) Fig. 1e . The DOX release rates were accelerated in the presence of light irradiation compared to the dark conditions. The fast DOX release from the micelles was most likely due to the degradation micelles by the photocleavage of the vinyldithioether bonds. These results suggest that micelles incorporated with a 1 O 2 -sensitive linker can effectively release co-loaded drugs under photodynamic conditions at the target cells, which may improve the overall therapeutic efficacy.
As designed, the light-responsive release of DOX from 1 O 2 -PMCe6-DOX was deemed to exhibit the spatio-temporal controlled synergistic anticancer effects. Therefore, the therapeutic potential of 1 O 2 -PM-Ce6-DOX was evaluated in vitro. Irrespective of light on/off, the 1 O 2 -PM and C-PM micelles demonstrated insignificant cytotoxicity due to the biocompatibility of PEG and PCL (Fig. S9 , ESI †). In addition, no significant toxicity was observed with 1 O 2 -PM-Ce6 and C-PM-Ce6 micelles under dark conditions (Fig. 2a) . However, 1 O 2 -PM-Ce6 and C-PM-Ce6 micelles showed slight cytotoxicity under light irradiation, which was ascribed to the cytotoxic effects of 1 O 2 generated from light-activated Ce6 (Fig. 2a) . In the cases of Ce6 and DOX loaded micelles under dark conditions, cell viability was retained above 95% for micellar concentrations of up to 5 mg mL
À1
. The insignificant toxicity of DOX-releasing micelles was due to the lower concentration of DOX compared with general DOX doses 16 for the in vitro test. Although each of 1 O 2 and DOX released from the micelles could not exert the effective cytotoxic effects on the cancer cells, the combinatorial use of them showed the significant anticancer efficiency. Especially, under light irradiation, the 1 O 2 -PM-Ce6-DOX micelle showed the most efficient therapeutic effects compared to the C-PM-Ce6-DOX micelle (Fig. 2b) . To demonstrate the potential of the micelles for intracellular delivery, cellular uptake and intracellular release behaviour of DOX from the micelles were evaluated using confocal laser scan microscopy. As shown in Fig. 3 , the strongest fluorescence in the nucleus was observed in the cells incubated with 1 O 2 -PM-Ce6-DOX micelles exposed to light compared to the dark conditions and control micelles, which could be attributed to the enhanced release of DOX by 1 O 2 -responsive destruction of the micelle. Therefore, it can be concluded that the 1 O 2 -PM-Ce6-DOX micelle showed the potential not only for reducing the unintended cytotoxic effects on the normal tissues during blood circulation, but also for exhibiting the effective anticancer effects only on tumours.
In summary, visible light-triggered intracellular co-delivery of an anticancer drug and a PS using biocompatible polymeric micelles bearing vinyldithioether as a 1 O 2 cleavable linker is realized for more effective photodynamic therapy. Given the high biocompatibility and ability to release drugs under photodynamic therapy conditions, the micellar system developed in this study could be a promising carrier for co-delivery of hydrophobic therapeutic drugs and PSs. This work was supported by the Research Center Program of IBS (Institute for Basic Science) in Korea (CA1203-02).
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